{"companyId":354153,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","fi","ja"],"companyName":"オリオン株式会社","headOfficeLocation":"オリオニンティエ1A、エスポー、02200、フィンランド","presidentName":"リイサ・フルメ","companySummary":null,"stockCode":"ORNBV","currency":"EUR","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["orionpharma.com"],"businessContents":["人間および獣医薬品の開発と製造","有効成分の製造"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://stockanalysis.com/quote/HEL/ORNBV/company/","scoreAbout":100,"scoreBusiness":100,"scoreGroup":0,"scoreCustomer":0}]}